Clinical trial
Interstitial Cystitis
NCT00056251 · ICOS Corporation, Industry · Completed
Key facts
| NCT number | NCT00056251 |
|---|---|
| Title | Interstitial Cystitis |
| Official title | A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of RTX Topical Solution in Patients With Interstitial Cystitis |
| Lead sponsor | ICOS Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Interstitial Cystitis |
| Intervention type | Procedure |
| Interventions | H&P, ECG, Blood tests, voiding diary, Cystoscopy |
| Enrollment | 150 |
| Start date | Jan 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Mar 10, 2003 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: